TrialBreast cancer research : BCR2025

Phase 1/2 study of H3B-6545 in women with locally advanced/metastatic estrogen receptor-positive, HER2-negative breast cancer.

Erika Hamilton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.